Lastly, the HDL-induced activation of eNOS is less effective in T2DM and in MetS, which contributes to several HDL functional defects such as an impaired capacity to promote vasodilatation and endothelium repair, or to counteract ROS production and inflammation. This evidence concerns the gene NOS3 and type 2 diabetes mellitus.